11/14/2024
3:57 PM | Actinium Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
12:33 PM | Actinium Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/08/2024
5:51 PM | Actinium Pharmaceuticals (Subject)
Bigger Capital, LLC (Filed by)
| Form SC 13G/A | |
11/06/2024
6:30 AM | Actinium Pharmaceuticals (Filer)
| Form ARS | |
11/05/2024
4:00 PM | Actinium Pharmaceuticals (Filer)
| Form DEF 14A | |
11/05/2024
4:05 PM | Actinium Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
4:10 PM | Actinium Pharmaceuticals (Issuer)
Almenoff June Sherie (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/05/2024
4:12 PM | Actinium Pharmaceuticals (Issuer)
Almenoff June Sherie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/04/2024
10:47 AM | Actinium Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G | |
11/04/2024
10:10 AM | Actinium Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
08/05/2024
6:30 AM | Actinium Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
3:58 PM | Actinium Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/29/2024
4:00 PM | Actinium Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/09/2024
3:30 PM | Actinium Pharmaceuticals (Subject)
Bigger Capital, LLC (Filed by)
| Form SC 13G/A | |
02/05/2024
11:15 PM | Actinium Pharmaceuticals (Filer)
| Form EFFECT | |
02/02/2024
4:03 PM | Actinium Pharmaceuticals (Filer)
| Form S-3/A | |
01/29/2024
2:26 PM | Actinium Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G | |
12/29/2023
4:17 PM | Actinium Pharmaceuticals (Issuer)
Actinium Pharmaceuticals (Issuer)
SETH SANDESH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:18 PM | Actinium Pharmaceuticals (Issuer)
Shetty Ajit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:20 PM | Actinium Pharmaceuticals (Issuer)
Actinium Pharmaceuticals (Issuer)
O'Loughlin Steve (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:23 PM | Actinium Pharmaceuticals (Issuer)
Steinhart Richard I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:24 PM | Actinium Pharmaceuticals (Issuer)
Nicholson, C. David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:15 PM | Actinium Pharmaceuticals (Issuer)
Chell Jeffrey W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
4:00 PM | Actinium Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
